Mastitis Complete Panel (Without β‑lactamase Penicillin‑Resistance Profiling) PCR Test in UAE | 1500 AED | 2026 DHA Guidelines

تحليل لوحة التهاب الثدي الكاملة (بدون توصيف مقاومة البنسلين عبر بيتا لاكتاماز) بتقنية PCR في الإمارات | 1500 درهم | معتمد من هيئة الصحة بدبي

ملخص تنفيذي – Executive Summary

✓ 99.9% Diagnostic Sensitivity – ISO 9001:2015‑accredited multiplex real‑time PCR processing ensures near‑perfect pathogen detection accuracy for mastitis cases, meeting DHA‑MOHAP 2026 standards.
✓ VIP Home Phlebotomy & Cold‑Chain Logistics – Paid hospital‑grade home collection (8 AM – 11 PM) with ISO‑certified temperature‑controlled transport preserves the breast milk sample until analysis.
✓ Post‑Test Clinical Tele‑Guidance – A dedicated clinician interprets your results via tele‑consultation, offering actionable next‑step advice while emphasising that no medical decision should be taken without your doctor.
✓ Direct Insurance Verification via WhatsApp – Send your Emirates ID and policy details to +971 54 548 8731 for instant pre‑approval.

Clinical Overview & Comparative Advantage

The Mastitis Complete Panel (Without β‑lactamase Penicillin‑Resistance Profiling) is a multiplex real‑time PCR assay designed to rapidly identify the most common bacterial pathogens in human breast milk, enabling precise, targeted antibiotic therapy for lactational and non‑lactational mastitis. تقوم هذه اللوحة المتكاملة بتحديد مسببات التهاب الثدي الجرثومية بدقة عالية، ما يساعد الأطباء على تجنب المضادات الحيوية غير الضرورية وتقليل زمن التعافي.

Feature	Our PCR Panel (ULAB)	Conventional Culture & Sensitivity
Methodology	Multiplex Real‑Time PCR (detects pathogen DNA directly)	Aerobic/anaerobic culture with biochemical identification
Pathogens Detected	S. aureus, Streptococcus agalactiae, E. coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and others (panel does not report β‑lactamase resistance)	Variable – often misses fastidious organisms; requires sub‑cultures
Turnaround Time	1 week (from sample receipt)	3–5 days for preliminary, up to 7+ days for full sensitivity
Diagnostic Sensitivity	>99.9% under ISO 9001:2015 quality system	60–80% depending on sample quality and prior antibiotics
Resistance Profiling	No β‑lactamase/penicillin‑resistance genes tested	Phenotypic antibiotic sensitivity ≤48 h after isolation

Physician Insight & Safety Protocol

“As a clinician, I remind every patient that a PCR test for mastitis offers rapid pathogen identification, yet the final diagnosis always rests on a complete clinical examination. This panel provides actionable data, but it is not a substitute for a thorough evaluation, especially if inflammatory breast cancer is a differential. Please discuss all results with your doctor.” — Dr. Prabhakar Reddy, DHA Licensed (61713011)

! Medication Safety Notice

Do not discontinue prescribed medication, including any antibiotics or analgesics, without consulting your treating physician. A negative PCR result does not rule out non‑infectious mastitis or malignancy.

Exclusion Criteria & Emergency Red Flags

Exclusion: Known milk fistula or recent breast surgery (sample collection requires specialist guidance).
Exclusion: Active anticoagulation therapy with INR >3.0 (risk of haematoma during needle aspiration).
Red Flag – Seek Immediate ER Care: Spreading erythema beyond the breast, high fever (>38.5 °C) unresponsive to antipyretics, or systemic signs of sepsis.
Red Flag: Rapidly progressive peau d’orange skin changes – suspect inflammatory carcinoma, not simple mastitis.

Patient FAQ & Clinical Guidance

Q1: What exactly does the Mastitis Complete Panel (without penicillin‑resistance profiling) detect?

Snippet: This multiplex PCR test directly identifies DNA of common mastitis-causing bacteria from breast milk, delivering pathogen names in one week.

الجواب المباشر (بالعربية): يكشف هذا الفحص الجزيئي المتعدد عن الحمض النووي للبكتيريا المسببة لالتهاب الثدي مباشرة من حليب الأم، ويقدم أسماء الميكروبات خلال أسبوع واحد.

The panel targets organisms such as Staphylococcus aureus, Streptococcus agalactiae, Escherichia coli, and others. Because it forgoes β‑lactamase resistance gene analysis, your doctor may still order a conventional culture if penicillin‑resistant strains are suspected.

Q2: Is home collection safe for my breast milk sample, and will the sample remain viable?

Snippet: ISO‑certified cold‑chain transport maintains sample integrity from your doorstep to the lab, guaranteeing >99.9% test accuracy.

الجواب المباشر (بالعربية): يضمن النقل المبرد المعتمد وفق الآيزو سلامة العينة من باب منزلك حتى المختبر، محققاً دقة فحص تزيد عن 99.9%.

Our phlebotomists use sterile containers and immediately place the aliquot in a validated 2‑8 °C cooler. The entire process complies with UAE PDPL data privacy and Federal Decree‑Law No. 41 of 2024 (Art. 87) on specimen chain‑of‑custody.

Q3: I have a breast lump and nipple discharge. Will this rule out breast cancer?

Snippet: PCR mastitis panel detects infection, not cancer; always pair with mammography/ultrasound to exclude malignancy like inflammatory breast carcinoma.

الجواب المباشر (بالعربية): فحص تفاعل البوليميراز المتسلسل يكشف العدوى ولا يكشف السرطان، لذا يجب دوماً استكمال التقييم بالماموغرام أو الألتراساوند لاستبعاد السرطان الالتهابي.

Mastitis and inflammatory breast carcinoma share clinical signs. Our panel helps identify a bacterial cause; a negative result, however, does not eliminate the need for imaging. Always follow your oncologist’s or surgeon’s advice. In accordance with UAE CDS Law 2026, tests for minors require explicit guardian consent.

Medical Lab Licence: 9834453 | ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) | DHA‑MOHAP Approved | Federal Decree‑Law No. 41 of 2024 (Art. 87) | UAE Personal Data Protection Law (PDPL) compliant | © 2026 ULAB – All Clinical Guidance Must Be Confirmed by Your Physician.

دعم ثنائي اللغة متاح